Binding Sites are compared using Shaper.
For more information, please see the following publication:
Desaphy J. et al. Comparison and Druggability Prediction of protein-Ligand Binding sites from pharmacophore-annotated cavity shapes J. Chem. Inf. Model., 2012, 52(8), pp2287-2299
Binding Sites are considered as similar when the similarity value is greater than 0.44
PDB ID | HET | Uniprot Name | EC Number |
---|---|---|---|
4fv0 | EK3 | Mitogen-activated protein kinase 1 | 2.7.11.24 |
PDB ID | HET | Uniprot Name | EC Number | Binding Site Similarity |
Align |
---|---|---|---|---|---|
4fv0 | EK3 | Mitogen-activated protein kinase 1 | 2.7.11.24 | 1.000 | |
4fuy | EK2 | Mitogen-activated protein kinase 1 | 2.7.11.24 | 0.602 | |
4g6n | EK0 | Mitogen-activated protein kinase 1 | 2.7.11.24 | 0.590 | |
4fv4 | EK7 | Mitogen-activated protein kinase 1 | 2.7.11.24 | 0.535 | |
4i22 | IRE | Epidermal growth factor receptor | 2.7.10.1 | 0.522 | |
3qyw | 6PB | Mitogen-activated protein kinase 1 | 2.7.11.24 | 0.516 | |
4fv9 | E71 | Mitogen-activated protein kinase 1 | 2.7.11.24 | 0.514 | |
2oji | 33A | Mitogen-activated protein kinase 1 | 2.7.11.24 | 0.510 | |
4bco | T6Q | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.505 | |
4fmq | ANP | Mitogen-activated protein kinase 1 | 2.7.11.24 | 0.504 | |
4fux | E75 | Mitogen-activated protein kinase 1 | 2.7.11.24 | 0.503 | |
4kbk | 1QG | Casein kinase I isoform delta | 2.7.11.1 | 0.503 | |
2c3i | IYZ | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.501 | |
4g6o | E28 | Mitogen-activated protein kinase 1 | 2.7.11.24 | 0.498 | |
4qmx | H8H | Serine/threonine-protein kinase 24 | 2.7.11.1 | 0.498 | |
2z7l | S91 | Mitogen-activated protein kinase 1 | 2.7.11.24 | 0.497 | |
4aac | AAV | Mitogen-activated protein kinase 14 | / | 0.496 | |
4lop | SB4 | Mitogen-activated protein kinase 14 | / | 0.495 | |
4b99 | R4L | Mitogen-activated protein kinase 7 | 2.7.11.24 | 0.493 | |
3uvq | FS8 | Mitogen-activated protein kinase 14 | / | 0.492 | |
2izr | BRK | Casein kinase I isoform gamma-3 | 2.7.11.1 | 0.491 | |
1tvo | FRZ | Mitogen-activated protein kinase 1 | 2.7.11.24 | 0.490 | |
4fv1 | EK4 | Mitogen-activated protein kinase 1 | 2.7.11.24 | 0.490 | |
1jpa | ANP | Ephrin type-B receptor 2 | 2.7.10.1 | 0.489 | |
3r04 | UNQ | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.489 | |
4kb8 | 1QN | Casein kinase I isoform delta | 2.7.11.1 | 0.489 | |
2wtd | ZZK | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.488 | |
2xp2 | VGH | ALK tyrosine kinase receptor | 2.7.10.1 | 0.488 | |
4kiq | 1RA | Mitogen-activated protein kinase 14 | / | 0.488 | |
2w0j | ZAT | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.486 | |
4dfl | 0K0 | Tyrosine-protein kinase SYK | 2.7.10.2 | 0.486 | |
4gt3 | ATP | Mitogen-activated protein kinase 1 | 2.7.11.24 | 0.486 | |
4s34 | ANP | Mitogen-activated protein kinase 1 | 2.7.11.24 | 0.486 | |
2qo9 | ANP | Ephrin type-A receptor 3 | 2.7.10.1 | 0.485 | |
4c4j | X21 | Dual specificity protein kinase TTK | 2.7.12.1 | 0.485 | |
4oj4 | DIF | Peroxisome proliferator-activated receptor gamma | / | 0.485 | |
4f4p | 0SB | Tyrosine-protein kinase SYK | 2.7.10.2 | 0.484 | |
4hgl | 0YO | Casein kinase I isoform gamma-3 | 2.7.11.1 | 0.484 | |
3sa0 | NRA | Mitogen-activated protein kinase 1 | 2.7.11.24 | 0.483 | |
4bcq | TJF | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.483 | |
4u97 | STU | Interleukin-1 receptor-associated kinase 4 | 2.7.11.1 | 0.482 | |
4fob | 0US | ALK tyrosine kinase receptor | 2.7.10.1 | 0.481 | |
4kba | 1QM | Casein kinase I isoform delta | 2.7.11.1 | 0.481 | |
4riy | ADP | Epidermal growth factor receptor | 2.7.10.1 | 0.481 | |
1byg | STU | Tyrosine-protein kinase CSK | / | 0.480 | |
2dq7 | STU | Tyrosine-protein kinase Fyn | 2.7.10.2 | 0.480 | |
2izs | BRQ | Casein kinase I isoform gamma-3 | 2.7.11.1 | 0.480 | |
2vu3 | LZE | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.480 | |
2phk | ATP | Phosphorylase b kinase gamma catalytic chain, skeletal muscle/heart isoform | 2.7.11.19 | 0.479 | |
4erk | OLO | Mitogen-activated protein kinase 1 | 2.7.11.24 | 0.479 | |
2yir | YIR | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.478 | |
3uyt | 0CK | Casein kinase I isoform delta | 2.7.11.1 | 0.478 | |
4ft7 | H3K | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.478 | |
4hjo | AQ4 | Epidermal growth factor receptor | 2.7.10.1 | 0.478 | |
4loq | SB4 | Mitogen-activated protein kinase 14 | / | 0.478 | |
4yuq | KS1 | Calmodulin-like domain protein kinase | / | 0.478 | |
4fv2 | EK5 | Mitogen-activated protein kinase 1 | 2.7.11.24 | 0.477 | |
2brg | DFY | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.476 | |
3orm | AGS | Serine/threonine protein kinase | / | 0.476 | |
4fv7 | E94 | Mitogen-activated protein kinase 1 | 2.7.11.24 | 0.476 | |
2b9i | ADP | Mitogen-activated protein kinase FUS3 | 2.7.11.24 | 0.475 | |
2cgx | 3D3 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.475 | |
4anq | VGH | ALK tyrosine kinase receptor | 2.7.10.1 | 0.475 | |
2gs7 | ANP | Epidermal growth factor receptor | 2.7.10.1 | 0.474 | |
3we4 | 5FI | Ribosomal protein S6 kinase beta-1 | 2.7.11.1 | 0.474 | |
1k6v | XN2 | Gag-Pol polyprotein | 3.4.23.16 | 0.473 | |
2ojj | 82A | Mitogen-activated protein kinase 1 | 2.7.11.24 | 0.473 | |
2p33 | J07 | Mitogen-activated protein kinase 10 | 2.7.11.24 | 0.473 | |
2xvd | AS6 | Ephrin type-B receptor 4 | 2.7.10.1 | 0.473 | |
3ac3 | KSH | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.473 | |
3gc9 | B45 | Mitogen-activated protein kinase 11 | 2.7.11.24 | 0.473 | |
3gub | GUB | Death-associated protein kinase 1 | 2.7.11.1 | 0.473 | |
4rrv | ATP | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.473 | |
3k5u | PFQ | Aurora kinase A | 2.7.11.1 | 0.472 | |
2w1f | L0F | Aurora kinase A | 2.7.11.1 | 0.471 | |
3fi3 | JK2 | Mitogen-activated protein kinase 10 | 2.7.11.24 | 0.471 | |
4bfm | ANP | Maternal embryonic leucine zipper kinase | 2.7.11.1 | 0.471 | |
5e8x | STU | TGF-beta receptor type-1 | 2.7.11.30 | 0.471 | |
1ywr | LI9 | Mitogen-activated protein kinase 14 | / | 0.470 | |
2hxl | 422 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.470 | |
3bgq | VX2 | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.470 | |
3mdv | CL6 | Cholesterol 24-hydroxylase | / | 0.470 | |
3vs5 | VSG | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.470 | |
3w55 | 1FM | Mitogen-activated protein kinase 1 | 2.7.11.24 | 0.470 | |
4k18 | 1OB | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.470 | |
1pmn | 984 | Mitogen-activated protein kinase 10 | 2.7.11.24 | 0.469 | |
2vx0 | 7X7 | Ephrin type-B receptor 4 | 2.7.10.1 | 0.469 | |
4aw1 | ATP | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.469 | |
4bcn | T9N | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.469 | |
4jq8 | KJ8 | Epidermal growth factor receptor | 2.7.10.1 | 0.469 | |
4l42 | 5FI | Ribosomal protein S6 kinase beta-1 | 2.7.11.1 | 0.469 | |
1qpd | STU | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.468 | |
1unl | RRC | Cyclin-dependent-like kinase 5 | 2.7.11.1 | 0.468 | |
3fln | 3FN | Mitogen-activated protein kinase 14 | / | 0.468 | |
3hrf | ATP | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.468 | |
3mtf | A3F | Activin receptor type-1 | 2.7.11.30 | 0.468 | |
3r9d | X6B | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.468 | |
3rm6 | 18Z | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.468 | |
3s4q | NK0 | Mitogen-activated protein kinase 14 | / | 0.468 | |
3wec | AUI | Cytochrome P450 | / | 0.468 | |
4a06 | ATP | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.468 | |
4bb4 | 32W | Ephrin type-B receptor 4 | 2.7.10.1 | 0.468 | |
1qcf | PP1 | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.467 | |
2b9f | ADP | Mitogen-activated protein kinase FUS3 | 2.7.11.24 | 0.467 | |
2r43 | G3G | Gag-Pol polyprotein | 3.4.23.16 | 0.467 | |
2y9q | ANP | Mitogen-activated protein kinase 1 | 2.7.11.24 | 0.467 | |
3lfn | A27 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.467 | |
4aa5 | NQB | Mitogen-activated protein kinase 14 | / | 0.467 | |
4mcv | 29K | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.467 | |
2h8h | H8H | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.466 | |
3vs2 | VSB | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.466 | |
4gk3 | L87 | Ephrin type-A receptor 3 | 2.7.10.1 | 0.466 | |
1kv2 | B96 | Mitogen-activated protein kinase 14 | / | 0.465 | |
2bdj | HET | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.465 | |
2hxq | 373 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.465 | |
2x9f | X9F | Ephrin type-B receptor 4 | 2.7.10.1 | 0.465 | |
2zva | 1N1 | Tyrosine-protein kinase Lyn | 2.7.10.2 | 0.465 | |
3b8r | 887 | Vascular endothelial growth factor receptor 2 | 2.7.10.1 | 0.465 | |
3hrc | ATP | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.465 | |
3r83 | Z14 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.465 | |
4bdh | WVI | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.465 | |
4bkz | 1WS | Maternal embryonic leucine zipper kinase | 2.7.11.1 | 0.465 | |
2q61 | SF1 | Peroxisome proliferator-activated receptor gamma | / | 0.464 | |
2w05 | FRT | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.464 | |
3cyl | VIT | Basic phospholipase A2 homolog piratoxin-2 | / | 0.464 | |
3ncg | BK1 | Calmodulin-domain protein kinase 1, putative | / | 0.464 | |
3rai | X85 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.464 | |
3t11 | 3T1 | Gag-Pol polyprotein | 3.4.23.16 | 0.464 | |
3ttj | JBI | Mitogen-activated protein kinase 10 | 2.7.11.24 | 0.464 | |
3w1f | 1O5 | Dual specificity protein kinase TTK | 2.7.12.1 | 0.464 | |
4g17 | 0VN | Casein kinase I isoform gamma-3 | 2.7.11.1 | 0.464 | |
1k6c | MK1 | Gag-Pol polyprotein | 3.4.23.16 | 0.463 | |
1xjd | STU | Protein kinase C theta type | 2.7.11.13 | 0.463 | |
2b55 | D31 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.463 | |
2bal | PQA | Mitogen-activated protein kinase 14 | / | 0.463 | |
2i4z | DRH | Peroxisome proliferator-activated receptor gamma | / | 0.463 | |
2itq | ITQ | Epidermal growth factor receptor | 2.7.10.1 | 0.463 | |
3ddq | RRC | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.463 | |
3ggg | NAD | Prephenate dehydrogenase | / | 0.463 | |
3hl7 | I47 | Mitogen-activated protein kinase 14 | / | 0.463 | |
3vs4 | VSF | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.463 | |
4c3f | 7KW | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.463 | |
4c4i | X20 | Dual specificity protein kinase TTK | 2.7.12.1 | 0.463 | |
4ft5 | H2K | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.463 | |
4u9a | STU | Interleukin-1 receptor-associated kinase 4 | 2.7.11.1 | 0.463 | |
4xey | 1N1 | Tyrosine-protein kinase ABL1 | 2.7.10.2 | 0.463 | |
1pkd | UCN | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.462 | |
1xl2 | 189 | Gag-Pol polyprotein | 3.4.23.16 | 0.462 | |
2bdf | 24A | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.462 | |
2e9n | 76A | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.462 | |
2fb8 | 215 | Serine/threonine-protein kinase B-raf | 2.7.11.1 | 0.462 | |
2np8 | CC3 | Aurora kinase A | 2.7.11.1 | 0.462 | |
2ycs | NXP | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.462 | |
3o0g | 3O0 | Cyclin-dependent-like kinase 5 | 2.7.11.1 | 0.462 | |
3t8o | ATP | Rhodopsin kinase | / | 0.462 | |
3vs7 | KS1 | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.462 | |
4ftu | 7HK | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.462 | |
4hnf | 16W | Casein kinase I isoform delta | 2.7.11.1 | 0.462 | |
1oi9 | N20 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.461 | |
1u54 | ACP | Activated CDC42 kinase 1 | / | 0.461 | |
2c47 | 5ID | Casein kinase I isoform gamma-2 | / | 0.461 | |
2w9s | TOP | Dihydrofolate reductase type 1 from Tn4003 | 1.5.1.3 | 0.461 | |
3a4o | STU | Tyrosine-protein kinase Lyn | 2.7.10.2 | 0.461 | |
3nwq | 2NC | Gag-Pol polyprotein | 3.4.23.16 | 0.461 | |
3ocg | OCG | Mitogen-activated protein kinase 14 | / | 0.461 | |
3pvu | QRW | Beta-adrenergic receptor kinase 1 | 2.7.11.15 | 0.461 | |
3r8v | Z62 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.461 | |
3uim | ANP | BRASSINOSTEROID INSENSITIVE 1-associated receptor kinase 1 | 2.7.10.1 | 0.461 | |
4fr4 | STU | Serine/threonine-protein kinase 32A | 2.7.11.1 | 0.461 | |
4i0s | 1B5 | Tyrosine-protein kinase SYK | 2.7.10.2 | 0.461 | |
4n0s | DHC | Mitogen-activated protein kinase 1 | 2.7.11.24 | 0.461 | |
4n70 | 2HX | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.461 | |
2acx | ANP | G protein-coupled receptor kinase 6 | 2.7.11.16 | 0.460 | |
2hma | SAM | tRNA-specific 2-thiouridylase MnmA | / | 0.460 | |
2itn | ANP | Epidermal growth factor receptor | 2.7.10.1 | 0.460 | |
2ym4 | 4YM | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.460 | |
3vrz | VRZ | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.460 | |
3vth | APC | Carbamoyltransferase | / | 0.460 | |
4fod | 0UV | ALK tyrosine kinase receptor | 2.7.10.1 | 0.460 | |
4oae | CLM | Uncharacterized protein | / | 0.460 | |
1qpj | STU | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.459 | |
1u4d | DBQ | Activated CDC42 kinase 1 | / | 0.459 | |
2cdz | 23D | Serine/threonine-protein kinase PAK 4 | 2.7.11.1 | 0.459 | |
2wtc | VGM | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.459 | |
2xk9 | XK9 | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.459 | |
2ym7 | YM7 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.459 | |
3amb | VX6 | cAMP-dependent protein kinase catalytic subunit alpha | 2.7.11.11 | 0.459 | |
3ml8 | ML8 | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.459 | |
3zew | STU | Ephrin type-B receptor 4 | 2.7.10.1 | 0.459 | |
4aa4 | QC0 | Mitogen-activated protein kinase 14 | / | 0.459 | |
4fz6 | 0VG | Tyrosine-protein kinase SYK | 2.7.10.2 | 0.459 | |
4l3j | 5FI | Ribosomal protein S6 kinase beta-1 | 2.7.11.1 | 0.459 | |
4n6z | 2HW | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.459 | |
4nif | ANP | Mitogen-activated protein kinase 1 | 2.7.11.24 | 0.459 | |
5e8w | STU | TGF-beta receptor type-1 | 2.7.11.30 | 0.459 | |
1w8c | N69 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.458 | |
2br1 | PFP | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.458 | |
2bts | U32 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.458 | |
2iw9 | 4SP | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.458 | |
2vwy | 7X5 | Ephrin type-B receptor 4 | 2.7.10.1 | 0.458 | |
3cbl | STU | Tyrosine-protein kinase Fes/Fps | 2.7.10.2 | 0.458 | |
3cgf | JNF | Mitogen-activated protein kinase 10 | 2.7.11.24 | 0.458 | |
3h0s | B38 | Acetyl-CoA carboxylase | / | 0.458 | |
3ma3 | 01I | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.458 | |
3r2b | 05B | MAP kinase-activated protein kinase 2 | 2.7.11.1 | 0.458 | |
3tmz | 06X | Cytochrome P450 2B4 | 1.14.14.1 | 0.458 | |
4cfn | JYM | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.458 | |
4jr3 | KJR | Epidermal growth factor receptor | 2.7.10.1 | 0.458 | |
4mxo | DB8 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.458 | |
4otw | DB8 | Receptor tyrosine-protein kinase erbB-3 | 2.7.10.1 | 0.458 | |
4s32 | ANP | Mitogen-activated protein kinase 1 | 2.7.11.24 | 0.458 | |
1e1x | NW1 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.457 | |
1h1r | 6CP | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.457 | |
2h96 | 893 | Mitogen-activated protein kinase 8 | 2.7.11.24 | 0.457 | |
2hog | 710 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.457 | |
2uze | C95 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.457 | |
2w7x | D1A | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.457 | |
3umx | Q18 | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.457 | |
3w18 | N13 | Aurora kinase A | 2.7.11.1 | 0.457 | |
4flh | 14K | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.457 | |
4g1w | G1W | Mitogen-activated protein kinase 8 | 2.7.11.24 | 0.457 | |
4hee | 14R | Peroxisome proliferator-activated receptor gamma | / | 0.457 | |
4hgt | 15G | Casein kinase I isoform delta | 2.7.11.1 | 0.457 | |
4ks8 | B49 | Serine/threonine-protein kinase PAK 6 | 2.7.11.1 | 0.457 | |
4lmu | QUE | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.457 | |
1oiy | N41 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.456 | |
2b1p | AIZ | Mitogen-activated protein kinase 10 | 2.7.11.24 | 0.456 | |
2brh | DFW | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.456 | |
2xik | J60 | Serine/threonine-protein kinase 25 | 2.7.11.1 | 0.456 | |
3hx4 | ANP | Calmodulin-domain protein kinase 1 | / | 0.456 | |
3pvw | QRX | Beta-adrenergic receptor kinase 1 | 2.7.11.15 | 0.456 | |
3tdv | GDP | Gentamicin resistance protein | / | 0.456 | |
3vs6 | VSH | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.456 | |
4a4v | YFD | Peroxisome proliferator-activated receptor gamma | / | 0.456 | |
4cy8 | FDA | 2-hydroxybiphenyl-3-monooxygenase | / | 0.456 | |
4g16 | 0VM | Casein kinase I isoform gamma-3 | 2.7.11.1 | 0.456 | |
4qmw | KS1 | Serine/threonine-protein kinase 24 | 2.7.11.1 | 0.456 | |
5dgz | L20 | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.456 | |
1oiu | N76 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.455 | |
2cgw | 3C3 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.455 | |
2gek | GDP | Phosphatidyl-myo-inositol mannosyltransferase | 2.4.1.57 | 0.455 | |
2of2 | 547 | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.455 | |
2vn0 | TDZ | Cytochrome P450 2C8 | / | 0.455 | |
3bgp | VX1 | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.455 | |
3elj | GS7 | Mitogen-activated protein kinase 8 | 2.7.11.24 | 0.455 | |
3f69 | XDR | Serine/threonine-protein kinase PknB | 2.7.11.1 | 0.455 | |
3le6 | 2BZ | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.455 | |
3mpa | SB2 | Mitogen-activated protein kinase 14 | / | 0.455 | |
4fsr | HKC | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.455 | |
4g2f | C07 | Ephrin type-A receptor 3 | 2.7.10.1 | 0.455 | |
4gk2 | L66 | Ephrin type-A receptor 3 | 2.7.10.1 | 0.455 | |
4ix6 | ADP | Uncharacterized protein | / | 0.455 | |
4nb6 | 444 | Nuclear receptor ROR-gamma | / | 0.455 | |
1e8z | STU | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.454 | |
2etm | 7PY | Focal adhesion kinase 1 | 2.7.10.2 | 0.454 | |
2i4j | DRJ | Peroxisome proliferator-activated receptor gamma | / | 0.454 | |
3ad6 | KSC | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.454 | |
3ics | COA | Coenzyme A disulfide reductase | / | 0.454 | |
3jy0 | LYG | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.454 | |
3s2p | PMU | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.454 | |
4acc | 7YG | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.454 | |
4b0g | VEK | Aurora kinase A | 2.7.11.1 | 0.454 | |
4bf2 | STU | Mitogen-activated protein kinase kinase kinase 5 | 2.7.11.25 | 0.454 | |
4c4g | 7RO | Dual specificity protein kinase TTK | 2.7.12.1 | 0.454 | |
4ieb | ANP | Calmodulin-domain protein kinase 1 | / | 0.454 | |
4jay | FAD | UDP-N-acetylenolpyruvoylglucosamine reductase | / | 0.454 | |
1eh4 | IC1 | Casein kinase I homolog 1 | 2.7.11.1 | 0.453 | |
1i7i | AZ2 | Peroxisome proliferator-activated receptor gamma | / | 0.453 | |
1nvs | UCM | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.453 | |
2chz | 093 | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.453 | |
2exc | JNK | Mitogen-activated protein kinase 10 | 2.7.11.24 | 0.453 | |
2f2c | AP9 | Cyclin-dependent kinase 6 | 2.7.11.22 | 0.453 | |
2jn3 | JN3 | Fatty acid-binding protein, liver | / | 0.453 | |
2wot | ZZG | TGF-beta receptor type-1 | 2.7.11.30 | 0.453 | |
2znn | S44 | Peroxisome proliferator-activated receptor alpha | / | 0.453 | |
3nbw | TR4 | Ketohexokinase | / | 0.453 | |
4aw0 | ATP | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.453 | |
4gj2 | 0XH | Non-receptor tyrosine-protein kinase TYK2 | 2.7.10.2 | 0.453 | |
4mbl | 26L | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.453 | |
4s33 | ANP | Mitogen-activated protein kinase 1 | 2.7.11.24 | 0.453 | |
1k6t | XN1 | Gag-Pol polyprotein | 3.4.23.16 | 0.452 | |
1okz | UCN | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.452 | |
1yi3 | LY2 | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.452 | |
2brn | DF1 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.452 | |
2c3q | GTX | Glutathione S-transferase theta-1 | 2.5.1.18 | 0.452 | |
2chx | 090 | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.452 | |
2i4p | DRH | Peroxisome proliferator-activated receptor gamma | / | 0.452 | |
2j2i | LY4 | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.452 | |
2xj1 | XJ1 | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.452 | |
3ddp | RC8 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.452 | |
3nwy | GTP | Uridylate kinase | / | 0.452 | |
3ori | AGS | Serine/threonine protein kinase | / | 0.452 | |
3uvp | 048 | Mitogen-activated protein kinase 14 | / | 0.452 | |
3w33 | W19 | Epidermal growth factor receptor | 2.7.10.1 | 0.452 | |
4aoj | V4Z | High affinity nerve growth factor receptor | 2.7.10.1 | 0.452 | |
4bdb | ODO | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.452 | |
4c3r | ACP | Aurora kinase A | 2.7.11.1 | 0.452 | |
4c58 | 824 | Cyclin-G-associated kinase | 2.7.11.1 | 0.452 | |
4fsw | HK6 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.452 | |
4iwo | 1H4 | Serine/threonine-protein kinase TBK1 | 2.7.11.1 | 0.452 | |
4jqe | ANP | Casein kinase II subunit alpha | 2.7.11.1 | 0.452 | |
4xld | BRL | Peroxisome proliferator-activated receptor gamma | / | 0.452 | |
5c7o | NAD | Glyceraldehyde-3-phosphate dehydrogenase, testis-specific | 1.2.1.12 | 0.452 | |
1k6p | XN3 | Gag-Pol polyprotein | 3.4.23.16 | 0.451 | |
1nvq | UCN | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.451 | |
1os1 | ATP | Phosphoenolpyruvate carboxykinase (ATP) | / | 0.451 | |
1v0p | PVB | Cell division control protein 2 homolog | 2.7.11.22 | 0.451 | |
1zar | ADP | RIO-type serine/threonine-protein kinase Rio2 | 2.7.11.1 | 0.451 | |
2a4l | RRC | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.451 | |
2f4b | EHA | Peroxisome proliferator-activated receptor gamma | / | 0.451 | |
2nry | STU | Interleukin-1 receptor-associated kinase 4 | 2.7.11.1 | 0.451 | |
2wmq | ZYQ | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.451 | |
2xb7 | GUI | ALK tyrosine kinase receptor | 2.7.10.1 | 0.451 | |
2xm9 | LWH | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.451 | |
2ycq | UPX | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.451 | |
3nlb | 5BE | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.451 | |
4bb3 | KKA | Isopenicillin N synthase | 1.21.3.1 | 0.451 | |
4enh | FVX | Cholesterol 24-hydroxylase | / | 0.451 | |
4id7 | 1G0 | Activated CDC42 kinase 1 | / | 0.451 | |
4jlc | SU6 | Serine/threonine-protein kinase TBK1 | 2.7.11.1 | 0.451 | |
4oav | ACP | 2-5A-dependent ribonuclease | 3.1.26 | 0.451 | |
4wkq | IRE | Epidermal growth factor receptor | 2.7.10.1 | 0.451 | |
4xx9 | ATP | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.451 | |
4yut | FMN | Family 3 adenylate cyclase | / | 0.451 | |
5ajq | DB8 | Serine/threonine-protein kinase 10 | 2.7.11.1 | 0.451 | |
2c3l | IDZ | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.450 | |
2c4g | 514 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.450 | |
2vz6 | FEF | Calcium/calmodulin-dependent protein kinase type II subunit alpha | 2.7.11.17 | 0.450 | |
3bgz | VX3 | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.450 | |
3dog | NNN | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.450 | |
3ogq | AB1 | Pol polyprotein | / | 0.450 | |
3say | OFT | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.450 | |
3sc1 | 3S1 | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.450 | |
3vs3 | VSE | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.450 | |
3w32 | W32 | Epidermal growth factor receptor | 2.7.10.1 | 0.450 | |
4bcm | T7Z | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.450 | |
4bl1 | ANP | Maternal embryonic leucine zipper kinase | 2.7.11.1 | 0.450 | |
4c62 | XWW | Tyrosine-protein kinase JAK2 | / | 0.450 | |
4dtk | 7LI | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.450 | |
4feq | 0T8 | Tyrosine-protein kinase receptor TYRO3 | 2.7.10.1 | 0.450 | |
4fv3 | EK6 | Mitogen-activated protein kinase 1 | 2.7.11.24 | 0.450 | |
4hgs | 15G | Casein kinase I isoform gamma-3 | 2.7.11.1 | 0.450 | |
4jbo | WPH | Aurora kinase A | 2.7.11.1 | 0.450 | |
4l52 | 1UL | Mitogen-activated protein kinase kinase kinase 7 | 2.7.11.25 | 0.450 | |
1di8 | DTQ | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.449 | |
2bfy | H1N | Aurora kinase B-A | 2.7.11.1 | 0.449 | |
2qa2 | FAD | Polyketide oxygenase CabE | / | 0.449 | |
2qoc | ANP | Ephrin type-A receptor 3 | 2.7.10.1 | 0.449 | |
2vwz | 7X6 | Ephrin type-B receptor 4 | 2.7.10.1 | 0.449 | |
3kf7 | L9G | Mitogen-activated protein kinase 14 | / | 0.449 | |
3mvl | 38P | Mitogen-activated protein kinase 14 | / | 0.449 | |
3nwx | KVS | Gag-Pol polyprotein | 3.4.23.16 | 0.449 | |
3qql | X03 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.449 | |
3wfj | NAD | 2-dehydropantoate 2-reductase | / | 0.449 | |
4fad | 0TB | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.449 | |
4fl1 | ANP | Tyrosine-protein kinase SYK | 2.7.10.2 | 0.449 | |
4ftr | 5HK | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.449 | |
4k0y | 1OA | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.449 | |
4kin | 1M8 | Mitogen-activated protein kinase 14 | / | 0.449 | |
5dr9 | SKE | Aurora kinase A | 2.7.11.1 | 0.449 | |
1ad5 | ANP | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.448 | |
1ee0 | CAA | 2-pyrone synthase | / | 0.448 | |
1fvt | 106 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.448 | |
1gqt | ACP | Ribokinase | / | 0.448 | |
1ie4 | T44 | Transthyretin | / | 0.448 | |
2dv7 | SAH | Diphthine synthase | / | 0.448 | |
2ghm | LIC | Mitogen-activated protein kinase 14 | / | 0.448 | |
2hw2 | RFP | Rifampin ADP-ribosyl transferase | / | 0.448 | |
2iw8 | 4SP | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.448 | |
2qd4 | CHD | Ferrochelatase, mitochondrial | 4.99.1.1 | 0.448 | |
2vwu | 7X1 | Ephrin type-B receptor 4 | 2.7.10.1 | 0.448 | |
2vwx | 7X4 | Ephrin type-B receptor 4 | 2.7.10.1 | 0.448 | |
2y6o | 1N1 | Ephrin type-A receptor 4 | 2.7.10.1 | 0.448 | |
2yiq | YIQ | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.448 | |
3oom | 507 | Activin receptor type-1 | 2.7.11.30 | 0.448 | |
3oro | AGS | Serine/threonine protein kinase | / | 0.448 | |
3rkb | 12Z | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.448 | |
4asf | 62U | ATP-dependent molecular chaperone HSP82 | / | 0.448 | |
4ft0 | HK9 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.448 | |
4fyn | 0VE | Tyrosine-protein kinase SYK | 2.7.10.2 | 0.448 | |
4i23 | 1C9 | Epidermal growth factor receptor | 2.7.10.1 | 0.448 | |
1h1s | 4SP | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.447 | |
1hvh | Q82 | Gag-Pol polyprotein | 3.4.23.16 | 0.447 | |
1u8f | NAD | Glyceraldehyde-3-phosphate dehydrogenase | 1.2.1.12 | 0.447 | |
1wvx | BD4 | Death-associated protein kinase 1 | 2.7.11.1 | 0.447 | |
2cch | ATP | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.447 | |
2gtk | 208 | Peroxisome proliferator-activated receptor gamma | / | 0.447 | |
2j0k | 4ST | Focal adhesion kinase 1 | 2.7.10.2 | 0.447 | |
2j7t | 274 | Serine/threonine-protein kinase 10 | 2.7.11.1 | 0.447 | |
2q5g | 1FA | Peroxisome proliferator-activated receptor delta | / | 0.447 | |
2vtp | LZ9 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.447 | |
2y4g | TIR | TamL | / | 0.447 | |
2yfe | YFE | Peroxisome proliferator-activated receptor gamma | / | 0.447 | |
3cd3 | STU | Tyrosine-protein kinase Fes/Fps | 2.7.10.2 | 0.447 | |
3fmk | FMK | Mitogen-activated protein kinase 14 | / | 0.447 | |
3pe6 | ZYH | Monoglyceride lipase | / | 0.447 | |
3qrt | X14 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.447 | |
3qwk | X62 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.447 | |
3vjo | ANP | Epidermal growth factor receptor | 2.7.10.1 | 0.447 | |
4gub | 0Y4 | Casein kinase II subunit alpha | 2.7.11.1 | 0.447 | |
4hys | 1BJ | Mitogen-activated protein kinase 8 | 2.7.11.24 | 0.447 | |
4i0t | 1B6 | Tyrosine-protein kinase SYK | 2.7.10.2 | 0.447 | |
4ix5 | ANP | Uncharacterized protein | / | 0.447 | |
4k11 | 0J9 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.447 | |
5ack | ATP | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.447 | |
5awm | ANP | Stress-activated protein kinase JNK | 2.7.11.24 | 0.447 | |
5c8w | PCG | cGMP-dependent protein kinase 2 | 2.7.11.12 | 0.447 | |
1kbo | FAD | NAD(P)H dehydrogenase [quinone] 1 | 1.6.5.2 | 0.446 | |
1lso | NAD | Hydroxyacyl-coenzyme A dehydrogenase, mitochondrial | 1.1.1.35 | 0.446 | |
1oky | STU | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.446 | |
1rek | B8L | cAMP-dependent protein kinase catalytic subunit alpha | 2.7.11.11 | 0.446 | |
2e9o | A58 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.446 | |
2j0d | ERY | Cytochrome P450 3A4 | / | 0.446 | |
2o65 | MYF | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.446 | |
2om9 | AJA | Peroxisome proliferator-activated receptor gamma | / | 0.446 | |
2q59 | 240 | Peroxisome proliferator-activated receptor gamma | / | 0.446 | |
2vrx | 447 | Aurora kinase B-A | 2.7.11.1 | 0.446 | |
3c50 | ADP | Rhodopsin kinase | / | 0.446 | |
3cs8 | BRL | Peroxisome proliferator-activated receptor gamma | / | 0.446 | |
3et7 | 349 | Protein-tyrosine kinase 2-beta | 2.7.10.2 | 0.446 | |
3gbu | ATP | Uncharacterized sugar kinase PH1459 | 2.7.1 | 0.446 | |
3hdm | MMG | Serine/threonine-protein kinase Sgk1 | 2.7.11.1 | 0.446 | |
3nbv | ANP | Ketohexokinase | / | 0.446 | |
3nd1 | SAH | Precorrin-6A synthase (Deacetylating) | / | 0.446 | |
3she | I85 | MAP kinase-activated protein kinase 3 | 2.7.11.1 | 0.446 | |
4eok | 4SP | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.446 | |
4ez5 | 0RS | Cyclin-dependent kinase 6 | 2.7.11.22 | 0.446 | |
4ful | 0VU | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.446 | |
4gk4 | L90 | Ephrin type-A receptor 3 | 2.7.10.1 | 0.446 | |
4h3c | 0YZ | Ditrans,polycis-undecaprenyl-diphosphate synthase ((2E,6E)-farnesyl-diphosphate specific) | 2.5.1.31 | 0.446 | |
4mvf | STU | Calcium-dependent protein kinase 2 | 2.7.11.1 | 0.446 | |
4qmt | H1N | Serine/threonine-protein kinase 24 | 2.7.11.1 | 0.446 | |
4y95 | 746 | Tyrosine-protein kinase | / | 0.446 | |
4yzc | STU | Serine/threonine-protein kinase/endoribonuclease IRE1 | 2.7.11.1 | 0.446 | |
5dt3 | ATP | Aurora kinase A | 2.7.11.1 | 0.446 | |
1bdl | IM1 | Gag-Pol polyprotein | 3.4.23.16 | 0.445 | |
1ol7 | ADP | Aurora kinase A | 2.7.11.1 | 0.445 | |
1phh | FAD | p-hydroxybenzoate hydroxylase | / | 0.445 | |
1wvg | APR | CDP-glucose 4,6-dehydratase | 4.2.1.45 | 0.445 | |
1wvy | STU | Death-associated protein kinase 1 | 2.7.11.1 | 0.445 | |
1yhs | STU | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.445 | |
2py3 | ACP | Fibroblast growth factor receptor 2 | / | 0.445 | |
2pzp | ACP | Fibroblast growth factor receptor 2 | / | 0.445 | |
2r0u | M54 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.445 | |
2vd5 | BI8 | Myotonin-protein kinase | 2.7.11.1 | 0.445 | |
2x1n | X1N | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.445 | |
2x8e | X8E | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.445 | |
2ydi | YDI | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.445 | |
3l8p | 0CE | Angiopoietin-1 receptor | 2.7.10.1 | 0.445 | |
3qcs | 3Q1 | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.445 | |
3qx4 | X4B | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.445 | |
3r1q | X75 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.445 | |
3r9h | Z67 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.445 | |
3sp6 | IL2 | Peroxisome proliferator-activated receptor alpha | / | 0.445 | |
3tti | KBI | Mitogen-activated protein kinase 10 | 2.7.11.24 | 0.445 | |
3w9r | A8S | Abscisic acid receptor PYL9 | / | 0.445 | |
4b12 | NHW | Glycylpeptide N-tetradecanoyltransferase | / | 0.445 | |
4bqp | VMY | Enoyl-[acyl-carrier-protein] reductase [NADH] | 1.3.1.9 | 0.445 | |
4c4h | 7RO | Dual specificity protein kinase TTK | 2.7.12.1 | 0.445 | |
4h3q | ANP | Mitogen-activated protein kinase 1 | 2.7.11.24 | 0.445 | |
4o0u | ADN | Aurora kinase A | 2.7.11.1 | 0.445 | |
5dr2 | ATP | Aurora kinase A | 2.7.11.1 | 0.445 | |
1pyx | ANP | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.444 | |
1vyw | 292 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.444 | |
1y0s | 331 | Peroxisome proliferator-activated receptor delta | / | 0.444 | |
2brb | PFQ | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.444 | |
2e9u | A25 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.444 | |
2e9v | 85A | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.444 | |
2p4y | C03 | Peroxisome proliferator-activated receptor gamma | / | 0.444 | |
2q5p | 241 | Peroxisome proliferator-activated receptor gamma | / | 0.444 | |
2qo7 | ANP | Ephrin type-A receptor 3 | 2.7.10.1 | 0.444 | |
3bhe | BZN | Gag-Pol polyprotein | 3.4.23.16 | 0.444 | |
3c0i | 3AM | Peripheral plasma membrane protein CASK | 2.7.11.1 | 0.444 | |
3dxj | NE6 | DNA-directed RNA polymerase subunit beta | / | 0.444 | |
3dxj | NE6 | DNA-directed RNA polymerase subunit beta' | / | 0.444 | |
3hll | I45 | Mitogen-activated protein kinase 14 | / | 0.444 | |
3ig7 | EFP | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.444 | |
3kga | LX9 | MAP kinase-activated protein kinase 2 | 2.7.11.1 | 0.444 | |
3qtz | X42 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.444 | |
3v5l | 0G1 | Tyrosine-protein kinase ITK/TSK | 2.7.10.2 | 0.444 | |
3vt8 | YI3 | Vitamin D3 receptor | / | 0.444 | |
3zh8 | C58 | Protein kinase C iota type | 2.7.11.13 | 0.444 | |
4fv8 | E63 | Mitogen-activated protein kinase 1 | 2.7.11.24 | 0.444 | |
4h8n | NDP | NADPH-dependent conjugated polyketone reductase C2 | / | 0.444 | |
4jbq | VX6 | Aurora kinase A | 2.7.11.1 | 0.444 | |
4l3l | 5FI | Ribosomal protein S6 kinase beta-1 | 2.7.11.1 | 0.444 | |
4nky | 3QZ | Steroid 17-alpha-hydroxylase/17,20 lyase | / | 0.444 | |
4nr4 | 2LK | CREB-binding protein | / | 0.444 | |
4rqv | ATP | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.444 | |
5aaa | VGH | ALK tyrosine kinase receptor | 2.7.10.1 | 0.444 | |
5eai | FAD | NAD(P)H dehydrogenase [quinone] 1 | 1.6.5.2 | 0.444 | |
5eyp | LOC | Tubulin beta chain | / | 0.444 | |
1aq1 | STU | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.443 | |
1i7g | AZ2 | Peroxisome proliferator-activated receptor alpha | / | 0.443 | |
1ie9 | VDX | Vitamin D3 receptor | / | 0.443 | |
2dsi | SAH | Diphthine synthase | / | 0.443 | |
2j0m | 4ST | Focal adhesion kinase 1 | 2.7.10.2 | 0.443 | |
2vxo | XMP | GMP synthase [glutamine-hydrolyzing] | 6.3.5.2 | 0.443 | |
2zjw | REF | Casein kinase II subunit alpha | 2.7.11.1 | 0.443 | |
3a99 | ANP | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.443 | |
3d1x | ROC | Gag-Pol polyprotein | 3.4.23.16 | 0.443 | |
3hmm | 855 | TGF-beta receptor type-1 | 2.7.11.30 | 0.443 | |
3mqe | 416 | Prostaglandin G/H synthase 2 | 1.14.99.1 | 0.443 | |
3q9x | EMO | Casein kinase II subunit alpha | 2.7.11.1 | 0.443 | |
3sqq | 99Z | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.443 | |
3th8 | TH9 | Ditrans,polycis-undecaprenyl-diphosphate synthase ((2E,6E)-farnesyl-diphosphate specific) | 2.5.1.31 | 0.443 | |
3w0s | ANP | Hygromycin-B 4-O-kinase | 2.7.1.163 | 0.443 | |
4e5y | NDP | GDP-L-fucose synthase | 1.1.1.271 | 0.443 | |
4fg7 | ATP | Calcium/calmodulin-dependent protein kinase type 1 | 2.7.11.17 | 0.443 | |
4iay | ADP | cAMP-dependent protein kinase catalytic subunit alpha | 2.7.11.11 | 0.443 | |
5eox | ADP | Type 4 fimbrial biogenesis protein PilM | / | 0.443 | |
1ouk | 084 | Mitogen-activated protein kinase 14 | / | 0.442 | |
1pjk | ANP | Casein kinase II subunit alpha | 2.7.11.1 | 0.442 | |
1uu8 | BI1 | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.442 | |
1yol | S03 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.442 | |
2ayp | 43A | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.442 | |
2v7a | 627 | Tyrosine-protein kinase ABL1 | 2.7.10.2 | 0.442 | |
2vgo | AD5 | Aurora kinase B-A | 2.7.11.1 | 0.442 | |
2x7g | PVB | SRSF protein kinase 2 | 2.7.11.1 | 0.442 | |
3emg | 685 | Tyrosine-protein kinase SYK | 2.7.10.2 | 0.442 | |
3kpk | FAD | Sulfide-quinone reductase | / | 0.442 | |
3q92 | XNB | Ketohexokinase | / | 0.442 | |
3qa2 | XNA | Ketohexokinase | / | 0.442 | |
3qai | XNN | Ketohexokinase | / | 0.442 | |
3qaq | QAQ | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.442 | |
4aw3 | MYV | Mycinamicin IV hydroxylase/epoxidase | / | 0.442 | |
4fl3 | ANP | Tyrosine-protein kinase SYK | 2.7.10.2 | 0.442 | |
4gh2 | HK0 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.442 | |
4ia2 | BIV | Vitamin D3 receptor A | / | 0.442 | |
4nks | 2M2 | Fibroblast growth factor receptor 1 | / | 0.442 | |
5ap5 | 7RO | Dual specificity protein kinase TTK | 2.7.12.1 | 0.442 | |
1zrz | BI1 | Protein kinase C iota type | 2.7.11.13 | 0.441 | |
2duv | 371 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.441 | |
2dwb | ANP | Aurora kinase A | 2.7.11.1 | 0.441 | |
2hfp | NSI | Peroxisome proliferator-activated receptor gamma | / | 0.441 | |
2hk5 | 1BM | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.441 | |
2i40 | BLZ | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.441 | |
2o2u | 738 | Mitogen-activated protein kinase 10 | 2.7.11.24 | 0.441 | |
2ycf | YCF | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.441 | |
2yfx | VGH | ALK tyrosine kinase receptor | 2.7.10.1 | 0.441 | |
2zdt | 46C | Mitogen-activated protein kinase 10 | 2.7.11.24 | 0.441 | |
3cgo | JNO | Mitogen-activated protein kinase 10 | 2.7.11.24 | 0.441 | |
3cy2 | MB9 | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.441 | |
3flz | FLZ | Mitogen-activated protein kinase 14 | / | 0.441 | |
3gxl | QIG | TGF-beta receptor type-1 | 2.7.11.30 | 0.441 | |
3h9f | 92M | Dual specificity protein kinase TTK | 2.7.12.1 | 0.441 | |
3nww | 3NW | Mitogen-activated protein kinase 14 | / | 0.441 | |
3oqu | A8S | Abscisic acid receptor PYL9 | / | 0.441 | |
3qu0 | X40 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.441 | |
3w0o | ADP | Hygromycin-B 4-O-kinase | 2.7.1.163 | 0.441 | |
4ewn | 0VR | Imidazole glycerol phosphate synthase subunit HisF | 4.1.3 | 0.441 | |
4gih | 0X5 | Non-receptor tyrosine-protein kinase TYK2 | 2.7.10.2 | 0.441 | |
4hge | 15V | Tyrosine-protein kinase JAK2 | / | 0.441 | |
4nkv | AER | Steroid 17-alpha-hydroxylase/17,20 lyase | / | 0.441 | |
4q72 | FAD | Bifunctional protein PutA | / | 0.441 | |
4rqk | ATP | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.441 | |
5cvh | ADP | Casein kinase II subunit alpha | 2.7.11.1 | 0.441 | |
5drd | ATP | Aurora kinase A | 2.7.11.1 | 0.441 | |
5dt4 | ATP | Aurora kinase A | 2.7.11.1 | 0.441 | |
1bl6 | SB6 | Mitogen-activated protein kinase 14 | / | 0.440 | |
1ckp | PVB | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.440 | |
1osv | CHC | Bile acid receptor | / | 0.440 | |
1uuo | BRF | Dihydroorotate dehydrogenase (quinone), mitochondrial | 1.3.5.2 | 0.440 | |
2brm | DFZ | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.440 | |
2cf6 | NAP | Cinnamyl alcohol dehydrogenase 5 | 1.1.1.195 | 0.440 | |
2i1m | 5CN | Macrophage colony-stimulating factor 1 receptor | 2.7.10.1 | 0.440 | |
2ycr | HCW | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.440 | |
3efw | AK8 | Aurora kinase A | 2.7.11.1 | 0.440 | |
3fkl | FKL | Mitogen-activated protein kinase 14 | / | 0.440 | |
3l1s | Z92 | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.440 | |
3mfs | ANP | Peripheral plasma membrane protein CASK | 2.7.11.1 | 0.440 | |
3ndr | NAD | Pyridoxal 4-dehydrogenase | 1.1.1.107 | 0.440 | |
3qx2 | X63 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.440 | |
3r7y | Z04 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.440 | |
3tki | S25 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.440 | |
3tqh | NDP | Quinone oxidoreductase | / | 0.440 | |
3u4u | LNH | Casein kinase II subunit alpha | 2.7.11.1 | 0.440 | |
3vf9 | 477 | Tyrosine-protein kinase SYK | 2.7.10.2 | 0.440 | |
3wmx | NAD | NAD dependent epimerase/dehydratase | / | 0.440 | |
3zep | 1NX | Tyrosine-protein kinase JAK3 | 2.7.10.2 | 0.440 | |
4aot | GW8 | Serine/threonine-protein kinase 10 | 2.7.11.1 | 0.440 | |
4bcp | T3C | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.440 | |
4c02 | TAK | Activin receptor type-1 | 2.7.11.30 | 0.440 | |
4grb | 0XG | Casein kinase II subunit alpha | 2.7.11.1 | 0.440 | |
4idv | 13V | Mitogen-activated protein kinase kinase kinase 14 | 2.7.11.25 | 0.440 | |
4nk9 | 2K5 | Fibroblast growth factor receptor 1 | / | 0.440 | |
4o0r | X4Z | Serine/threonine-protein kinase PAK 1 | 2.7.11.1 | 0.440 | |
4qmp | DKI | Serine/threonine-protein kinase 24 | 2.7.11.1 | 0.440 | |
4zse | ANP | Epidermal growth factor receptor | 2.7.10.1 | 0.440 | |
5uvi | ZMA | Adenosine receptor A2a | / | 0.440 |